Description
Generic Name:
Dolutegravir + Lamivudine + Tenofovir Disoproxil Fumarate
Composition:
Each Acriptega Tablet contains:
- Dolutegravir (50mg): An integrase strand transfer inhibitor (INSTI) that prevents HIV from replicating.
- Lamivudine (300mg): A nucleoside reverse transcriptase inhibitor (NRTI) that blocks HIV’s ability to multiply.
- Tenofovir Disoproxil Fumarate (300mg): An NRTI that reduces viral replication and lowers the viral load.
- Excipients: [List of inactive ingredients such as binders, stabilizers, and coatings].
Indication:
Acriptega Tablet is indicated for:
- HIV-1 Infection Treatment: Used as a part of combination antiretroviral therapy (ART) for adults and adolescents.
- Reduction of HIV Transmission Risk: Helps in minimizing the chances of HIV spread.
- Post-Exposure Prophylaxis (PeP): May be prescribed to reduce HIV infection risk after exposure.
Storage Instructions:
- Store at room temperature (15-30°C) in a dry place.
- Keep away from direct sunlight, heat, and moisture.
- Store in its original container with the lid tightly closed.
- Keep out of reach of children and pets.
Uses of the Medicine:
- HIV Treatment: Helps to suppress the viral load and slow disease progression.
- Prevention of HIV Transmission: Lowers the risk of spreading HIV to others.
- Post-Exposure Prophylaxis (PeP): Can be used within 72 hours after HIV exposure.
- Combination Therapy: Part of a comprehensive HIV treatment plan.
Benefits of the Medicine:
- Highly Effective Viral Suppression: Reduces HIV levels in the bloodstream.
- Boosts Immune Function: Increases CD4 cell count, improving immunity.
- Once-Daily Dosage: Convenient and improves adherence to therapy.
- Well-Tolerated: Fewer side effects compared to older ART regimens.
Side Effects:
Common side effects may include:
- Nausea or vomiting
- Headache or dizziness
- Diarrhea or stomach discomfort
- Insomnia or unusual dreams
- Fatigue or muscle pain
Serious Side Effects Include:
Seek medical attention if you experience:
- Severe allergic reactions (swelling, difficulty breathing).
- Liver problems (yellowing of skin/eyes, persistent nausea).
- Lactic acidosis (rapid breathing, drowsiness, muscle pain).
- Kidney problems (reduced urination, swelling, back pain).
- Mood changes, including depression or suicidal thoughts.
How to Use the Medicine:
- Take Acriptega Tablet once daily, exactly as prescribed.
- Swallow the tablet whole with water; do not crush or chew.
- Can be taken with or without food.
- If used for PeP, complete the full 28-day course for effectiveness.
- Do not miss doses, as it can reduce treatment effectiveness.
How the Medicine Works:
Acriptega Tablet combines three antiretroviral agents that work together to suppress HIV. Dolutegravir prevents the virus from integrating into human DNA, while Lamivudine and Tenofovir Disoproxil Fumarate inhibit viral replication, lowering the viral load and improving immune function.
What If You Forget to Take the Medicine?
- Take the missed dose as soon as you remember.
- If it’s close to the next dose, skip the missed dose.
- Do not double the dose to make up for the missed one.
Quick Tips:
- Take Acriptega Tablet at the same time every day for optimal results.
- Avoid alcohol and recreational drugs to prevent interactions.
- Use protection (condoms) to minimize HIV transmission risk.
- Get regular blood tests to monitor kidney and liver function.
- Inform your doctor about any other medications you are taking.
Safety Advice
Alcohol
Caution is advised when consuming alcohol with Acriptega Tablet. Please consult your doctor for guidance.
Pregnancy
Acriptega Tablet is unsafe to use during pregnancy due to potential harm to the developing baby. It may only be prescribed in life-threatening situations where benefits outweigh the risks. Please consult your doctor.
Breastfeeding
There is insufficient information on the use of Acriptega Tablet while breastfeeding. Please consult your doctor before use.
Driving
It is uncertain whether Acriptega Tablet affects your ability to drive. Avoid driving if you experience drowsiness, dizziness, or reduced alertness.
Kidney
Limited data is available on the safety of Acriptega Tablet in patients with kidney disease. Dose adjustments may be necessary. Please consult your doctor.
Liver
Acriptega Tablet should be used with caution in patients with liver disease. Dose adjustments may be required based on the severity of the condition. Please consult your doctor.
FAQs:
Q: Can Acriptega Tablet cure HIV?
A: No, it helps manage HIV but does not cure it. Lifelong treatment is required.
Q: Can pregnant women take Acriptega Tablet?
A: It may be used in pregnancy, but only under medical supervision. Consult your doctor.
Q: How long does it take for Acriptega Tablet to work?
A: A significant viral load reduction can be observed within a few weeks.
Q: Can I take Acriptega Tablet with food?
A: Yes, it can be taken with or without food.
Related Lab Tests:
- HIV Viral Load Test (to monitor treatment progress).
- CD4 Cell Count (to assess immune function).
- Liver and Kidney Function Tests (to check for drug toxicity).
- Complete Blood Count (CBC) (to assess overall health).
